Silence Therapeutics Plc American Depository Share (SLN)
NASDAQ · Manufacturing · Pharmaceutical preparations
SLN price, last 12 months
Key stats
- Previous close
- $11.22
- Open
- $11.48
- Day range
- $11.03 – $11.48
- 52-week range
- $4.19 – $17.58
- Volume
- 848.8K
- Avg volume (20 days)
- 804.9K
- Market cap
- $694.9M
Performance
Technicals and fundamentals
About Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $694.9M